Correction to: Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes.


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
Jun 2020
Historique:
pubmed: 11 2 2020
medline: 11 2 2020
entrez: 11 2 2020
Statut: ppublish

Résumé

The Table 2 in the original version of this article contained a mistake in the alignment. Correct Table 2 presentation is presented here.

Identifiants

pubmed: 32040609
doi: 10.1007/s00259-020-04693-2
pii: 10.1007/s00259-020-04693-2
pmc: PMC7645486
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1611-1612

Commentaires et corrections

Type : ErratumFor

Auteurs

Jun Pyo Kim (JP)

Department of Neurology, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.

Jeonghun Kim (J)

Department of Bio-convergence Engineering, Korea University, Seoul, South Korea.

Yeshin Kim (Y)

Department of Neurology, Kangwon National University Hospital, Chuncheon, South Korea.

Seung Hwan Moon (SH)

Department of Nuclear Medicine, Samsung Medical Center, Seoul, South Korea.

Yu Hyun Park (YH)

Department of Neurology, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.

Sole Yoo (S)

Department of Cognitive Science, Yonsei University, Seoul, South Korea.

Hyemin Jang (H)

Department of Neurology, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.

Hee Jin Kim (HJ)

Department of Neurology, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.

Duk L Na (DL)

Department of Neurology, Samsung Medical Center, Seoul, South Korea.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea.
Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.

Sang Won Seo (SW)

Department of Neurology, Samsung Medical Center, Seoul, South Korea. sangwonseo@empal.com.
Samsung Alzheimer Research Center, Samsung Medical Center, Seoul, South Korea. sangwonseo@empal.com.
Neuroscience Center, Samsung Medical Center, Seoul, South Korea. sangwonseo@empal.com.
Department of Clinical Research Design & Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea. sangwonseo@empal.com.
Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea. sangwonseo@empal.com.

Joon-Kyung Seong (JK)

Department of Bio-convergence Engineering, Korea University, Seoul, South Korea. jkseong@korea.ac.kr.
School of Biomedical Engineering, Korea University, Seoul, South Korea. jkseong@korea.ac.kr.

Classifications MeSH